Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 5/20 | 0.35 |
| ▸ | ACHE | P22303 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9013751 | 0.98 | CHRNA7 (0.47) | CHRNA7CYP1A2CYP2D6ALDH1A1LMNA | |
| Sulfuric Acid SCHEMBL11346791 | 0.89 | CHRNA7 (0.42) | CHRNA7CYP1A2CYP2D6ALDH1A1LMNA | |
| Sulfuric Acid SCHEMBL11331738 | 0.88 | CYP1A2 (0.42) | CHRNA7CYP1A2CYP2D6 | |
| Sulfuric Acid SCHEMBL11383711 | 0.88 | CHRNA7 (0.41) | CHRNA7CYP1A2CYP2D6 | |
| SCHEMBL16673968 | 0.87 | CHRNA7 (0.53) | CHRNA7CYP1A2CYP2D6BCHEACHE | |
| Sulfuric Acid SCHEMBL11331697 | 0.86 | CYP1A2 (0.41) | CHRNA7CYP1A2CYP2D6 | |
| Sulfuric Acid SCHEMBL11380811 | 0.86 | CYP1A2 (0.41) | CHRNA7CYP1A2CYP2D6 | |
| SCHEMBL8492786 | 0.78 | CHRNA7 (0.47) | CHRNA7CYP1A2CYP2D6LMNABCHE | |
| SCHEMBL19942443 | 0.78 | CHRNA7 (0.47) | CHRNA7CYP1A2CYP2D6BCHEACHE | |
| Hydrochloric Acid SCHEMBL32681176 | 0.76 | CHRNA7 (0.46) | CHRNA7CYP1A2CYP2D6LMNAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0008447-B1 | N-(2,3-DIHYDROXYPROPYL)-PYRIDINIUM SULFATES, THEIR PREPARATION AND GALVANIC-ACID NICKEL BATHS CONTAINING THEM | Henkel Kommanditgesellschaft auf Aktien (DE) | 1981-10-21 | — | — | EP | claimed |
| US-20180217551-A1 | ELECTROPHOTOGRAPHIC MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KK (JP) | 2018-08-02 | — | — | US | disclosed |
| US-20180217551-A1 | ELECTROPHOTOGRAPHIC MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KK (JP) | 2018-08-02 | — | — | US | disclosed |
| US-20180217551-A1 | ELECTROPHOTOGRAPHIC MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KK (JP) | 2018-08-02 | — | — | US | disclosed |
| US-9964914-B2 | Electrophotographic member, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2018-05-08 | — | — | US | disclosed |
| US-9964914-B2 | Electrophotographic member, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2018-05-08 | — | — | US | disclosed |
| US-9964914-B2 | Electrophotographic member, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2018-05-08 | — | — | US | disclosed |
| US-20150331347-A1 | ELECTROPHOTOGRAPHIC MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2015-11-19 | — | — | US | disclosed |
| US-20150331347-A1 | ELECTROPHOTOGRAPHIC MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2015-11-19 | — | — | US | disclosed |
| US-20150331347-A1 | ELECTROPHOTOGRAPHIC MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2015-11-19 | — | — | US | disclosed |
| US-20090137045-A1 | Pyridinium Cationic Lipids as Gene Transfer Agents | BALABAN ALEXANDRU T | 2009-05-28 | — | — | US | disclosed |
| US-7456197-B2 | Pyridinium cationic lipids as gene transfer agents | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2008-11-25 | — | — | US | disclosed |
| US-20050196863-A1 | Pyridinium cationic lipids as gene transfer agents | TEXAS A & M UNIVERSITY, THE | 2005-09-08 | — | — | US | disclosed |
| EP-0008447-B1 | N-(2,3-DIHYDROXYPROPYL)-PYRIDINIUM SULFATES, THEIR PREPARATION AND GALVANIC-ACID NICKEL BATHS CONTAINING THEM | Henkel Kommanditgesellschaft auf Aktien (DE) | 1981-10-21 | — | — | EP | disclosed |
| US-4270987-A | AS LEVELING AGENT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1981-06-02 | — | — | US | disclosed |
| US-4270987-A | AS LEVELING AGENT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1981-06-02 | — | — | US | disclosed |
| US-4270987-A | AS LEVELING AGENT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1981-06-02 | — | — | US | disclosed |
| EP-0008447-A1 | N-(2,3-dihydroxypropyl)-pyridinium sulfates, their preparation and galvanic-acid nickel baths containing them | Henkel Kommanditgesellschaft auf Aktien (DE) | 1980-03-05 | — | — | EP | disclosed |
| EP-0008447-A1 | N-(2,3-dihydroxypropyl)-pyridinium sulfates, their preparation and galvanic-acid nickel baths containing them | Henkel Kommanditgesellschaft auf Aktien (DE) | 1980-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050196863-A1 | Pyridinium cationic lipids as gene transfer agents | PTDSS2, PLIN5, PTDSS1 | CHRNA7 2188/4885CYP1A2 2838/4885CYP2D6 3647/4885 |
| US-20090137045-A1 | Pyridinium Cationic Lipids as Gene Transfer Agents | PTDSS2, PLIN5, PTDSS1 | CHRNA7 2188/4885CYP1A2 2838/4885CYP2D6 3647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.